138 related articles for article (PubMed ID: 24228478)
1. [Novel treatment strategies for refractory patients with obsessive-compulsive disorder].
Nakamae T
Seishin Shinkeigaku Zasshi; 2013; 115(9):997-1003. PubMed ID: 24228478
[TBL] [Abstract][Full Text] [Related]
2. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M
Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713
[TBL] [Abstract][Full Text] [Related]
3. Serotonin reuptake inhibitor-cognitive behavioural therapy-second generation antipsychotic combination for severe treatment-resistant obsessive-compulsive disorder. A prospective observational study.
Tundo A; Salvati L; Cieri L; Balestrini V; Di Spigno D; Orazi F; Iommi M; Necci R
Int J Psychiatry Clin Pract; 2022 Nov; 26(4):395-400. PubMed ID: 35323098
[TBL] [Abstract][Full Text] [Related]
4. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].
Kordon A; Zurowski B; Wahl K; Hohagen F
Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636
[TBL] [Abstract][Full Text] [Related]
5. Cognitive-behavioural therapy augments the effects of deep brain stimulation in obsessive-compulsive disorder.
Mantione M; Nieman DH; Figee M; Denys D
Psychol Med; 2014 Dec; 44(16):3515-22. PubMed ID: 25065708
[TBL] [Abstract][Full Text] [Related]
6. Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
de Oliveira MVS; de Barros PMF; de Mathis MA; Boavista R; Chacon P; Echevarria MAN; Ferrão YA; Vattimo EFQ; Lopes AC; Torres AR; Diniz JB; Fontenelle LF; Rosário MCD; Shavitt RG; Miguel EC; da Silva RMF; Costa DLDC
Braz J Psychiatry; 2023 May; 45(2):146-161. PubMed ID: 36749887
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers.
Van Ameringen M; Simpson W; Patterson B; Dell'Osso B; Fineberg N; Hollander E; Hranov L; Hranov G; Lochner C; Karamustafalioglu O; Marazziti D; Menchon JM; Nicolini H; Pallanti S; Stein DJ; Zohar J
J Psychopharmacol; 2014 Jun; 28(6):596-602. PubMed ID: 24429223
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological management of treatment-resistant obsessive-compulsive disorder.
Abudy A; Juven-Wetzler A; Zohar J
CNS Drugs; 2011 Jul; 25(7):585-96. PubMed ID: 21699270
[TBL] [Abstract][Full Text] [Related]
9. An update on the pharmacological treatment of obsessive-compulsive disorder.
Fontenelle LF; Nascimento AL; Mendlowicz MV; Shavitt RG; Versiani M
Expert Opin Pharmacother; 2007 Apr; 8(5):563-83. PubMed ID: 17376013
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.
Poppe C; Müller ST; Greil W; Walder A; Grohmann R; Stübner S
J Affect Disord; 2016 Aug; 200():89-96. PubMed ID: 27130958
[TBL] [Abstract][Full Text] [Related]
11. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
Bloch MH; Storch EA
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
[TBL] [Abstract][Full Text] [Related]
12. Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.
Fineberg NA; Reghunandanan S; Simpson HB; Phillips KA; Richter MA; Matthews K; Stein DJ; Sareen J; Brown A; Sookman D;
Psychiatry Res; 2015 May; 227(1):114-25. PubMed ID: 25681005
[TBL] [Abstract][Full Text] [Related]
13. Drug treatment of obsessive-compulsive disorder.
Kellner M
Dialogues Clin Neurosci; 2010; 12(2):187-97. PubMed ID: 20623923
[TBL] [Abstract][Full Text] [Related]
14. [Treatment-refractory OCD and its biological pathophysiology].
Nakao T
Seishin Shinkeigaku Zasshi; 2013; 115(9):981-9. PubMed ID: 24228476
[TBL] [Abstract][Full Text] [Related]
15. [Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?].
van Ingen Schenau WJ; Wisman PW
Tijdschr Psychiatr; 2007; 49(5):315-25. PubMed ID: 17492582
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder.
Walsh KH; McDougle CJ
Expert Opin Pharmacother; 2004 Oct; 5(10):2059-67. PubMed ID: 15461541
[TBL] [Abstract][Full Text] [Related]
17. The medical treatment of obsessive-compulsive disorder and anxiety.
Bandelow B
CNS Spectr; 2008 Sep; 13(9 Suppl 14):37-46. PubMed ID: 18849910
[TBL] [Abstract][Full Text] [Related]
18. Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review.
Sareen J; Kirshner A; Lander M; Kjernisted KD; Eleff MK; Reiss JP
J Affect Disord; 2004 Oct; 82(2):167-74. PubMed ID: 15488245
[TBL] [Abstract][Full Text] [Related]
19. Cognitive behavior therapy for obsessive-compulsive and related disorders.
Lewin AB; Wu MS; McGuire JF; Storch EA
Psychiatr Clin North Am; 2014 Sep; 37(3):415-45. PubMed ID: 25150570
[TBL] [Abstract][Full Text] [Related]
20. Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder.
O'Connor KP; Aardema F; Robillard S; Guay S; Pélissier MC; Todorov C; Borgeat F; Leblanc V; Grenier S; Doucet P
Acta Psychiatr Scand; 2006 May; 113(5):408-19. PubMed ID: 16603032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]